Stock Information
Neurogene Inc (NGNE)
Ticker Symbol: NGNE
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $386.20 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -3.16
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -25.27%
Latest News
-
JP Morgan Initiates Coverage On Neurogene with Overweight Rating, Announces Price Target of $60
Thu, Oct 8, 2026 9:56 AM
-
Neurogene 13G Filing Shows Jennison Associates Reports 11.1% Stake In Co. As Of Sept. 30
Tue, Oct 6, 2026 1:59 PM
Key Financials
Financial data not available
